Table 1. Selection of FIV vaccine strains.

      Acute immune alteration Homologous
protection
vaccinea
     

FIV isolate FIV
subtype
Blood
virus load
CD4
decrease
CD4/CD8
inversion
Clinical
disease
cell virus

Shizuoka (SHI) D + None None None Yes Yes
Petaluma (PET) A ++ Slight/none None None Yes Yes
Swiss Z2 (Z2)b A +++ Slight/none None None ? ?
Millan 2 (M2) B ++++ Moderate ? ? Yes No
Amsterdam 19 (AM19)b A ++++ ? ? ? No ?
Utrecht 113 (UT113)b A ++++ ? ? ? No ?
Bangston (BANG) Agag/Benv ++++ Moderate Moderate None No? No
Glasgow 8 (GL8)b A +++++ Major Major Major No No

aSource of the homologous protection results are from reviews (11, 14).
bAcute immune alteration and blood virus load are based on in vitro-derived inocula. Remaining strains are based on in vivo-derived inocula.